1-({[(1S)-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl]carbonyl}oxy)pyrrolidine-2,5-dione | 1534326-80-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 四氢异喹啉
• 英文名称: 1-({[(1S)-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl]carbonyl}oxy)pyrrolidine-2,5-dione
• 英文别名: 2,5-Dioxopyrrolidin-1-yl (S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate；(2,5-dioxopyrrolidin-1-yl) (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate
• CAS: 1534326-80-1
• 化学式: C₂₀H₁₈N₂O₄
• 分子量: 350.374
• InChiKey: QPONJQKOPGKHTE-IBGZPJMESA-N

物化性质

• 沸点：
  502.8±60.0 °C(Predicted)
• 密度：
  1.38±0.1 g/cm3(Predicted)
• 溶解度：
  可溶于二氯甲烷、乙酸乙酯

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  26
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  66.9
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  N,N'-二琥珀酰亚胺基碳酸酯 、 (S)-1-苯基-1,2,3,4-四氢异喹啉 以 乙腈 为溶剂， 反应 2.0h， 以78%的产率得到1-({[(1S)-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl]carbonyl}oxy)pyrrolidine-2,5-dione
  参考文献：
  名称：

  [EN] A PROCESS FOR THE PREPARATION OF SOLIFENACIN OR A SALT THEREOF
  [FR] PROCÉDÉ POUR LA PRÉPARATION DE SOLIFÉNACINE OU D'UN DE SES SELS

  摘要：

  本发明涉及一种改进的用于制备化合物Solifenacin或其式I盐的过程，更具体地说，本发明涉及一种经济可行且在工业上具有优势的过程，用于制备高纯度的Solifenacin或其式I盐。

  公开号：

  WO2014005601A1

文献信息

• Method for producing solifenacin or salts thereof
  申请人：Inakoshi Masatoshi

  公开号：US20070185329A1

  公开（公告）日：2007-08-09

  There is provided a novel method for producing solifenacin or a salt thereof which is useful as a medicine, particularly a therapeutic agent and/or a preventive agent for a urinary organ system disease such as pollakiuria or urinary incontinence. Illustratively, there are provided (1) a method for producing solifenacin in which 2-(1H-imidazolylcarbonyl)-1-phenyltetrahydroisoquinoline is used as the starting material, (2) a method for producing solifenacin succinate in which (1RS)-phenyltetrahydroisoquinoline-carboxylic acid quinuclidinyl ester is used as the starting material, (3) a method for producing solifenacin in which a lower alkyl quinuclidinyl carbonate is used as the starting material and (4) a method for producing solifenacin in which phenyltetrahydroisoquinoline-carboxylic acid secondary lower alkyl or tertiary lower alkyl ester is used as the starting material and allowed to react with an alkali metal lower alkoxide.

  提供了一种新的制备索利费南或其盐的方法，该方法可用作药物，特别是用于治疗和/或预防尿生殖器官疾病，如尿频或尿失禁的治疗剂和/或预防剂。例如，提供了以下四种方法：（1）使用2-（1H-咪唑基）-1-苯基四氢异喹啉作为起始材料制备索利费南的方法；（2）使用（1RS）-苯基四氢异喹啉-羧酸奎尼克啶酯作为起始材料制备索利费南琥珀酸盐的方法；（3）使用较低烷基奎尼库啶碳酸酯作为起始材料制备索利费南的方法；（4）使用苯基四氢异喹啉-羧酸次级较低烷基或三级较低烷基酯作为起始材料，并与碱金属较低烷氧化物反应制备索利费南的方法。
• PROCESS FOR PRODUCING SOLIFENACIN OR ITS SALT
  申请人：Astellas Pharma Inc.

  公开号：EP1757604A1

  公开（公告）日：2007-02-28

  There is provided a novel method for producing solifenacin or a salt thereof which is useful as a medicine, particularly a therapeutic agent and/or a preventive agent for a urinary organ system disease such as pollakiuria or urinary incontinence. Illustratively, there are provided (1) a method for producing solifenacin in which 2-(1H-imidazolylcarbonyl)-1-phenyltetrahydroisoquinoline is used as the starting material, (2) a method for producing solifenacin succinate in which (1RS)-phenyltetrahydroisoquinoline-carboxylic acid quinuclidinyl ester is used as the starting material, (3) a method for producing solifenacin in which a lower alkyl quinuclidinyl carbonate is used as the starting material and (4) a method for producing solifenacin in which phenyltetrahydroisoquinoline-carboxylic acid secondary lower alkyl or tertiary lower alkyl ester is used as the starting material and allowed to react with an alkali metal lower alkoxide.

  本发明提供了一种生产索利芬那新或其盐的新方法，该方法可用作药物，特别是泌尿器官系统疾病（如花粉尿症或尿失禁）的治疗剂和/或预防剂。示例性地，提供了(1)一种生产索利那新的方法，其中使用 2-(1H-咪唑羰基)-1-苯基四氢异喹啉作为起始原料；(2)一种生产索利那新琥珀酸酯的方法，其中使用(1RS)-苯基四氢异喹啉-羧酸奎宁酯作为起始原料、(4) 以苯基四氢异喹啉-羧酸仲低级烷基酯或叔低级烷基酯为起始原料，使其与碱金属低级烷氧基化合物反应，生产索利那新的方法。
• Synthesis of solifenacin monosuccinate
  申请人：Astellas Pharma Inc.

  公开号：EP2305676B1

  公开（公告）日：2012-10-17
• US7829715B2
  申请人：——

  公开号：US7829715B2

  公开（公告）日：2010-11-09
• [EN] A PROCESS FOR THE PREPARATION OF SOLIFENACIN OR A SALT THEREOF<br/>[FR] PROCÉDÉ POUR LA PRÉPARATION DE SOLIFÉNACINE OU D'UN DE SES SELS
  申请人：PHARMATHEN SA

  公开号：WO2014005601A1

  公开（公告）日：2014-01-09

  The present invention relates to an improved process for the preparation of Solifenacin or its salt of formula I, more particularly the present invention relates to an economically viable and industrially advantageous process for the preparation of highly pure Solifenacin or its salt of formula I.

  本发明涉及一种改进的用于制备化合物Solifenacin或其式I盐的过程，更具体地说，本发明涉及一种经济可行且在工业上具有优势的过程，用于制备高纯度的Solifenacin或其式I盐。